30 days FREE from Class 9 to DropperRegister free

In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:

NEET 2022BiologyBiotechnology and its Applications · Gene therapy
  • A. Retroviral vector is introduced into these lymphocytes.
  • B. Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stages
  • C. Lymphocytes from patient's blood are grown in culture, outside the body.
  • D. Genetically engineered lymphocytes are not immortal cells.
Show answer & explanation

Answer: (D) Genetically engineered lymphocytes are not immortal cells.

Explanation

Since the genetically engineered lymphocytes used in ADA gene therapy are not immortal cells, they eventually die out, requiring periodic infusion of the engineered cells to sustain therapeutic effect.

Practise every Biotechnology and its Applications question with a timer

Chapter tests, full NEET mocks, your score and weak topics — 70,000+ questions on YNeet.

Start free for 30 days

No payment, no card. Sign up in 30 seconds.

For Class 11, 12 and droppers, see what the YNeet NEET online course includes.

More Biotechnology and its Applications questions

All free Biotechnology and its Applications PYQs →